John-Paul Todd

7.1k total citations
16 papers, 697 citations indexed

About

John-Paul Todd is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, John-Paul Todd has authored 16 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Virology and 7 papers in Immunology. Recurrent topics in John-Paul Todd's work include HIV Research and Treatment (7 papers), Immune Cell Function and Interaction (6 papers) and Herpesvirus Infections and Treatments (4 papers). John-Paul Todd is often cited by papers focused on HIV Research and Treatment (7 papers), Immune Cell Function and Interaction (6 papers) and Herpesvirus Infections and Treatments (4 papers). John-Paul Todd collaborates with scholars based in United States, Switzerland and Brazil. John-Paul Todd's co-authors include Srinivas S. Rao, John R. Mascola, Gary J. Nabel, Michael Joyce, Richard A. Koup, Amarendra Pegu, Adrian B. McDermott, Xuejun Chen, Zhi-Yong Yang and Peter D. Kwong and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

John-Paul Todd

16 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John-Paul Todd United States 8 307 285 221 201 151 16 697
Alberto Clivio Italy 15 319 1.0× 367 1.3× 157 0.7× 129 0.6× 126 0.8× 30 720
Xiaocong Yu United States 9 168 0.5× 311 1.1× 174 0.8× 265 1.3× 185 1.2× 23 740
KATHY E. COBB United States 6 585 1.9× 328 1.2× 239 1.1× 216 1.1× 150 1.0× 7 754
Jennifer Jones United States 11 511 1.7× 388 1.4× 231 1.0× 138 0.7× 196 1.3× 16 837
Anthony L. Desbien United States 15 115 0.4× 470 1.6× 194 0.9× 166 0.8× 216 1.4× 20 738
Gaia Sciaranghella United States 10 389 1.3× 387 1.4× 231 1.0× 151 0.8× 97 0.6× 12 728
Christopher Sundling Sweden 20 453 1.5× 984 3.5× 233 1.1× 201 1.0× 282 1.9× 52 1.4k
Joan Joseph Spain 18 222 0.7× 239 0.8× 291 1.3× 199 1.0× 270 1.8× 38 787
Danushka K. Wijesundara Australia 16 120 0.4× 344 1.2× 184 0.8× 252 1.3× 195 1.3× 39 741
Bartek Zuber Sweden 18 247 0.8× 382 1.3× 192 0.9× 129 0.6× 176 1.2× 29 737

Countries citing papers authored by John-Paul Todd

Since Specialization
Citations

This map shows the geographic impact of John-Paul Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John-Paul Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John-Paul Todd more than expected).

Fields of papers citing papers by John-Paul Todd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John-Paul Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John-Paul Todd. The network helps show where John-Paul Todd may publish in the future.

Co-authorship network of co-authors of John-Paul Todd

This figure shows the co-authorship network connecting the top 25 collaborators of John-Paul Todd. A scholar is included among the top collaborators of John-Paul Todd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John-Paul Todd. John-Paul Todd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
King, Hannah A. D., Sung‐Youl Ko, Christine M. Fennessey, et al.. (2025). Antibody prophylaxis may mask subclinical SIV infections in macaques. Nature. 639(8053). 205–213. 1 indexed citations
2.
Chaimongkol, Natthawan, Bianca M. Nagata, Samuel Darko, et al.. (2024). A non-human primate model for human norovirus infection. Nature Microbiology. 9(3). 776–786. 7 indexed citations
3.
Ratnasiri, Kalani, Hong Zheng, Zhiyuan Yao, et al.. (2024). Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans. Cell Reports. 43(2). 113706–113706. 1 indexed citations
4.
King, Hannah A. D., Supriya Pokkali, Dohoon Kim, et al.. (2023). Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques. The Journal of Immunology. 211(11). 1643–1655. 2 indexed citations
5.
Ou, Li, I‐Ting Teng, Lijuan Yang, et al.. (2023). Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus. PLoS Pathogens. 19(9). e1011584–e1011584. 5 indexed citations
6.
Hait, Sabrina Helmold, Eun Sung Yang, Cuiping Liu, et al.. (2022). Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses. iScience. 25(10). 105067–105067. 1 indexed citations
7.
Todd, John-Paul, et al.. (2022). P.08 Phase 1 open-label trial of Rycal S48168 (ARM210) for RYR1-related myopathies. Neuromuscular Disorders. 32. S46–S46. 1 indexed citations
8.
Dias, Joana, Giulia Fabozzi, Mangaiarkarasi Asokan, et al.. (2021). Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging. Journal of Clinical Investigation. 131(17). 4 indexed citations
9.
Welles, Hugh C., Madeleine F. Jennewein, Rosemarie D. Mason, et al.. (2018). Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge. PLoS Pathogens. 14(12). e1007395–e1007395. 42 indexed citations
10.
Kanekiyo, Masaru, Wei Bu, Michael Joyce, et al.. (2015). Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell. 162(5). 1090–1100. 258 indexed citations
11.
Pegu, Amarendra, Mangaiarkarasi Asokan, Lan Wu, et al.. (2015). Activation and lysis of human CD4 cells latently infected with HIV-1. Nature Communications. 6(1). 8447–8447. 75 indexed citations
12.
Saunders, Kevin O., Amarendra Pegu, Ivelin S. Georgiev, et al.. (2015). Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. Journal of Virology. 89(11). 5895–5903. 71 indexed citations
13.
Pegu, Amarendra, Zhi-Yong Yang, Jeffrey C. Boyington, et al.. (2014). Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor. Science Translational Medicine. 6(243). 243ra88–243ra88. 169 indexed citations
14.
Gorres, J. Patrick, Kelly M. Lager, Wing-Pui Kong, et al.. (2011). DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs. Clinical and Vaccine Immunology. 18(11). 1987–1995. 46 indexed citations
15.
Pegu, Amarendra, Zhiyong Yang, John-Paul Todd, et al.. (2011). VRC01 provides sterilizing protection to non human primates from mucosal SHIV challenges (155.11). The Journal of Immunology. 186(1_Supplement). 155.11–155.11. 5 indexed citations
16.
Todd, John-Paul, et al.. (1987). Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.. PubMed. 6(5). 525–36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026